Similar articles

• Tumor vaccination for high-grade glioma.

  Schlegel PG, Eyrich M, Kramm C, van Gool S. Schlegel PG, et al. Pediatr Blood Cancer. 2010 Dec 15;55(7):1437. doi: 10.1002/pbc.22753. Epub 2010 Sep 16. Pediatr Blood Cancer. 2010. PMID: 20848641 No abstract available.
• Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours.

  Ardon H, De Vleeschouwer S, Van Calenbergh F, Claes L, Kramm CM, Rutkowski S, Wolff JE, Van Gool SW. Ardon H, et al. Pediatr Blood Cancer. 2010 Apr;54(4):519-25. doi: 10.1002/pbc.22319. Pediatr Blood Cancer. 2010. PMID: 19852061 Clinical Trial.
• [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].

  Hashimoto N, Tsuboi A, Chiba Y, Izumoto S, Oka Y, Yoshimine T, Sugiyama H. Hashimoto N, et al. Brain Nerve. 2009 Jul;61(7):805-14. Brain Nerve. 2009. PMID: 19618858 Review. Japanese.
• Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.

  Toda M, Iizuka Y, Kawase T, Uyemura K, Kawakami Y. Toda M, et al. Cancer Gene Ther. 2002 Apr;9(4):356-64. doi: 10.1038/sj.cgt.7700446. Cancer Gene Ther. 2002. PMID: 11960286
• Immunotherapy of surgical malignancies.

  Morse MA, Lyerly HK, Clay TM, Abdel-Wahab O, Chui SY, Garst J, Gollob J, Grossi PM, Kalady M, Mosca PJ, Onaitis M, Sampson JH, Seigler HF, Toloza EM, Tyler D, Vieweg J, Yang Y. Morse MA, et al. Curr Probl Surg. 2004 Jan;41(1):15-132. doi: 10.1016/S0011384003001321. Curr Probl Surg. 2004. PMID: 14749625 Review. No abstract available.